Tech Company Financing Transactions
Tobira Therapeutics Funding Round
Oxford Finance participated in a $15 million venture round for Tobira Therapeutics. The round was announced on 7/1/2014.
Transaction Overview
Company Name
Announced On
7/1/2014
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The facility will support the development of CVC for the treatment of nonalcoholic steatohepatitis (NASH) and for working capital and general corporate needs.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
701 Gateway Blvd. 200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Tobira Therapeutics acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in infectious diseases such as HIV/AIDS, hepatitis, and other associated infectious conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurent Fischer
Chief Financial Officer
Christopher Peetz
Chief Medical Officer
Eric Lefebvre
Chief Operating Officer
Helen Jenkins
VP - Regulatory Affairs
Martine Kraus
Browse more venture capital transactions:
Prev: 7/1/2014: Carterra venture capital transaction
Next: 7/1/2014: posto7 venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs